Clinical Trial Update: A Study of AK112 for Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial status update indicating that AK112's Phase 1/2 study in advanced solid tumors has been completed. The trial was sponsored by Akeso.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: COMPLETED